Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-003790-34Phase 4Completed
Phase 4, randomised, open-label trial of Salcrozine, sponsored by KU Leuven. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-003790-34.